Several studies have indicated that a caloric restriction mimetic or treatment for type 2 diabetes may reverse brain aging. Therefore, we investigated the effect of 1-deoxynojirimycin (DNJ), an alkaloid acting as an inhibitor of α-glucosidase, on age-related behavioral and biochemical changes. SAMP8 mice were randomly assigned to a control group labeled “old” or to the 10- or 20-mg/kg/day DNJ groups. The mice in the DNJ groups were administered DNJ orally from 3 to 9 months of age, and then, a “young” control group was added to analyze the age effect. The old controls exhibited significant declines in sensorimotor ability, open-field anxiety, spatial and nonspatial memory abilities, and age-related biochemical changes, including decreased serum insulin level; increased levels of insulin-like growth factor 1 receptor, presynaptic protein synaptotagmin-1, and astrocyte activation; and decreased levels of insulin receptor, brain-derived neurotrophic factor, presynaptic protein syntaxin-1, and acetylation of histones H4 at lysine 8 in the dorsal hippocampus. Significant correlations exist between the age-related behavioral deficits and the serological and histochemical data. Chronic DNJ treatment alleviated these age-related changes, and the 20-mg/kg/day DNJ group showed more significant improvement. Thus, DNJ may have the potential to maintain successful brain aging.
26 September 2022 in International Journal of Biological Macromolecules
Dextran is a polysaccharide with a high medicinal value. Thus, the chemical modifications of dextran, and the structural and physicochemical properties of its derivatives should be given focus. Dextran (Mw 5000 Da to 7500 Da) can complex with iron. In this study, dextran (Mw 5400 Da) was modified at different pH levels (8–14) by using NaOH and NaClO/NaBr. The carboxyl groups of the modified dextran were determined using infrared spectroscopy, and the carboxyl contents were compared. The results of high-performance liquid chromatography indicated that dextran was degraded during the modification. The crystallization and the structure of the carboxyl-modified dextran were investigated using X-ray diffraction, nuclear magnetic resonance, and quadrupole time-of-flight mass spectrometry. The physicochemical properties, i.e., solubility, and granule morphology, of the carboxyl-modified dextran were carefully characterized and compared. This work provides a theoretical foundation for the accurate selection of carboxyl-modified dextran and the development of a novel strategy for the preparation of metal complexes.